Why Sanara MedTech Inc.’s (SMTI) Stock Is Down 13.28%
As of Friday, October 16, Sanara MedTech Inc.’s SMTI share price has dipped by 13.28%, which has investors questioning if this is right time to buy.Jenna Brashear
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Michael Rose
Omar Beirat
Michael Rose
Rosalio Madrigal
| Share Statistics | SMTI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $301.0 | $372.7 | 33% |
|
| Shares Out (Mil) | 8.8 | 41.4 | 19% |
|
| Institutional Ownership | 51.0% | 84.0% | 36% |
|
| Float (Mil) | 3.8 | 35.6 | 10% |
|
| Beta | 1.20 | 0.87 | 70% |
|
| Avg Daily Volume (000s) | 63 | 323 | 31% |
|
| Price Change (52-week) |
52.2% | 57.5% | 88% |
|
| Growth | SMTI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 45.9% | 11.8% | 95% |
|
| Net Income (5yr) | (53.6%) | (5.7%) | 6% |
|
| EPS (5yr) | (41.8%) | 10.6% | 5 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 15.7% | (15.8%) | 74% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | $0.180 | $0.200 | $0.540 | |
| Month Ago EPS | $0.180 | $0.200 | $0.540 | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | $0.180 | $0.180 | $0.540 | |
| Year/Year Chg | (220.0%) | (544.4%) | (1,944%) | |
| Financials | SMTI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $112 | $125 | 27% |
|
| Net Income (TTM) (Mil) | ($3) | ($9) | 35% |
|
| EPS (TTM) | ($0.346) | ($0.300) | 29% |
|
| Operating Cash Flow (TTM) (Mil) | $7 | ($1) | 37% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $2 | 50% |
|
| Long-Term Debt (Q1) (Mil) | $48 | $21 | 38% |
|
| Enterprise Value (Q1) (Mil) | $329 | $381 | 31% |
|
| Valuation | SMTI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 39.49 | 2.58 | 98% |
|
| P/E | na | 25.8 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | SMTI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 93.0% | 59.5% | 94% |
|
| Net Margin | (2.7%) | (4.5%) | 27% |
|
| ROA | (4.2%) | (10.1%) | 30% |
|
| ROE | (43.7%) | (8.3%) | 16% |
|
| Liabilities to Assets | 89.4% | 45.8% | 85% |
|
| F-Score | 6 | 4 | 67% |
|
Sanara MedTech Inc. did not pass any screens on 11/17/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors